Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Biondi-Zoccai, 2020, SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners, Minerva Cardioangiol, 10.23736/S0026-4725.20.05250-0 Li, 2020, Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China, Clin Res Cardiol, 10.1007/s00392-020-01626-9 Zheng, 2020, COVID-19 and the cardiovascular system, Nat Rev Cardiol, 10.1038/s41569-020-0360-5 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 10.1016/S0140-6736(20)30566-3 Su, 2016, Epidemiology, genetic recombination, and pathogenesis of coronaviruses, Trends Microbiol, 24, 490, 10.1016/j.tim.2016.03.003 Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Ge, 2013, Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor, Nature, 503, 535, 10.1038/nature12711 Wang, 2008, SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway, Cell Res, 18, 290, 10.1038/cr.2008.15 Zhang, 2020, Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target, Intensive Care Med, 10.1007/s00134-020-05985-9 Dong, 2020, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis, 10.1016/S1473-3099(20)30120-1 Zhang, 2020, Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis, Int J Infect Dis, 93, 201, 10.1016/j.ijid.2020.02.033 Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention, JAMA, 10.1001/jama.2020.2648 Mahase, 2020, Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate, BMJ, 368, m641, 10.1136/bmj.m641 Mizumoto, 2020, Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020, Euro Surveill, 25, 2000180, 10.2807/1560-7917.ES.2020.25.10.2000180 Li, 2020, 2019 novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis, J Med Virol Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585 Murthy, 2020, Care for critically ill patients with COVID-19, JAMA, 10.1001/jama.2020.3633 Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med Lee, 2020, Are children less susceptible to COVID-19?, J Microbiol Immunol Infect, 10.1016/j.jmii.2020.02.011 Liu, 2020, Detection of Covid-19 in children in early January 2020 in Wuhan, China, N Engl J Med, 10.1056/NEJMc2003717 Chen, 2020, The SARS-CoV-2 vaccine pipeline: an overview, Curr Trop Med Rep, 10.1007/s40475-020-00201-6 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Liu, 2020, Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province, Chin Med J (Engl) Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med, 10.1001/jamainternmed.2020.0994 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 10.1056/NEJMoa2002032 Porcheddu, 2020, Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China, J Infect Dev Ctries, 14, 125, 10.3855/jidc.12600 Govaert, 1994, The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial, JAMA, 272, 1661, 10.1001/jama.1994.03520210045030 Liu, 2011, Aging and impaired immunity to influenza viruses: implications for vaccine development, Hum Vaccin, 7 Suppl, 94, 10.4161/hv.7.0.14568 Zidar, 2019, Association of lymphopenia with risk of mortality among adults in the US general population, JAMA Netw Open, 2, 10.1001/jamanetworkopen.2019.16526 Libby, 2009, Inflammation in atherosclerosis: from pathophysiology to practice, J Am Coll Cardiol, 54, 2129, 10.1016/j.jacc.2009.09.009 Tall, 2015, Cholesterol, inflammation and innate immunity, Nat Rev Immunol, 15, 104, 10.1038/nri3793 Saltiel, 2017, Inflammatory mechanisms linking obesity and metabolic disease, J Clin Invest, 127, 1, 10.1172/JCI92035 Kwong, 2018, Acute myocardial infarction after laboratory-confirmed influenza infection, N Engl J Med, 378, 345, 10.1056/NEJMoa1702090 Davis, 2006, Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology, J Am Coll Cardiol, 48, 1498, 10.1016/j.jacc.2006.09.004 Liu, 2020, First cases of COVID-19 in heart transplantation from China, J Heart Lung Transplant Aslam, 2020, COVID-19: yet another coronavirus challenge in transplantation, J Heart Lung Transplant, 10.1016/j.healun.2020.03.007 2009, Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients—Seattle, Washington, 2009, MMWR Morb Mortal Wkly Rep, 58, 893 Danziger-Isakov, 2009, The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation, J Heart Lung Transplant, 28, 1341, 10.1016/j.healun.2009.10.001 Sarkisian, 2016, Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins, Am J Med, 129, 446, 10.1016/j.amjmed.2015.11.006 Thygesen, 2018, Fourth universal definition of myocardial infarction (2018), J Am Coll Cardiol, 72, 2231, 10.1016/j.jacc.2018.08.1038 Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 10.1016/S2213-2600(20)30079-5 Lippi, 2020, Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis, Prog Cardiovasc Dis, 10.1016/j.pcad.2020.03.001 Alhogbani, 2016, Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus, Ann Saudi Med, 36, 78, 10.5144/0256-4947.2016.78 Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir Med, 10.1016/S2213-2600(20)30076-X Liu, 2020, Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury, Sci China Life Sci, 63, 364, 10.1007/s11427-020-1643-8 Hu, 2020, Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin, Eur Heart J Zeng, 2020, How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital, Intensive Care Med, 10.1007/s00134-020-05993-9 Wood Welt, 2020, Catheterization laboratory considerations during the coronavirus (COVID 19) pandemic: from tACC’s Interventional Council and SCAI, J Am Coll Cardiol, 10.1016/j.jacc.2020.03.021 Chen, 2020, SARS-CoV-2: a potential novel etiology of fulminant myocarditis, Herz, 10.1007/s00059-020-04909-z Buzon, 2015, Takotsubo cardiomyopathy triggered by influenza A virus, Intern Med, 54, 2017, 10.2169/internalmedicine.54.3606 Zompatori, 2014, Overview of current lung imaging in acute respiratory distress syndrome, Eur Respir Rev, 23, 519, 10.1183/09059180.00001314 Ferguson, 2012, The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material, Intensive Care Med, 38, 1573, 10.1007/s00134-012-2682-1 Ranieri, 2012, Acute respiratory distress syndrome: the Berlin definition, JAMA, 307, 2526 Karmpaliotis, 2007, Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema, Chest, 131, 964, 10.1378/chest.06-1247 MacLaren, 2020, Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation, JAMA, 10.1001/jama.2020.2342 Klok, 2020, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thrombosis Research Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, 10.1111/jth.14768 Fan, 2020, Hematologic parameters in patients with COVID-19 infection, Am J Hematol Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost Witt, 2018, American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy, Blood Adv, 2, 3257, 10.1182/bloodadvances.2018024893 Elfiky, 2020, Anti-HCV, nucleotide inhibitors, repurposing against COVID-19, Life Sci, 248, 117477, 10.1016/j.lfs.2020.117477 Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658 2007 2013 DeCarolis, 2016, Evaluation of a potential interaction between new regimens to treat hepatitis C and warfarin, Ann Pharmacother, 50, 909, 10.1177/1060028016660325 Frost, 2015, Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor, Br J Clin Pharmacol, 79, 838, 10.1111/bcp.12541 Mueck, 2013, Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects, Br J Clin Pharmacol, 76, 455, 10.1111/bcp.12075 Itkonen, 2019, Clopidogrel increases dasabuvir exposure with or without ritonavir, and ritonavir inhibits the bioactivation of clopidogrel, Clin Pharmacol Ther, 105, 219, 10.1002/cpt.1099 Marsousi, 2018, Impact of boosted antiretroviral therapy on the pharmacokinetics and efficacy of clopidogrel and prasugrel active metabolites, Clin Pharmacokinet, 57, 1347, 10.1007/s40262-018-0637-6 2011 2011 Angiolillo, 2017, International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies, Circulation, 136, 1955, 10.1161/CIRCULATIONAHA.117.031164 2015 Mulangu, 2019, A randomized, controlled trial of Ebola virus disease therapeutics, N Engl J Med, 381, 2293, 10.1056/NEJMoa1910993 Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 30, 269, 10.1038/s41422-020-0282-0 Gao, 2020, Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends, 14, 72, 10.5582/bst.2020.01047 Page, 2016, Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association, Circulation, 134, e32, 10.1161/CIR.0000000000000426 Tonnesmann, 2013, Chloroquine cardiomyopathy—a review of the literature, Immunopharmacol Immunotoxicol, 35, 434, 10.3109/08923973.2013.780078 Day, 2020, COVID-19: ibuprofen should not be used for managing symptoms, say doctors and scientists, BMJ, 368, m1086, 10.1136/bmj.m1086 Imai, 2005, Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, 436, 112, 10.1038/nature03712 Gurwitz, 2020, Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics, Drug Dev Res, 10.1002/ddr.21656 Ferrario, 2005, Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2, Circulation, 111, 2605, 10.1161/CIRCULATIONAHA.104.510461 van Doremalen, 2020, Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, N Engl J Med, 10.1056/NEJMc2004973 Chow, 2006, Conversion of operating theatre from positive to negative pressure environment, J Hosp Infect, 64, 371, 10.1016/j.jhin.2006.07.020 Adams, 2020, Supporting the health care workforce during the COVID-19 global epidemic, JAMA, 10.1001/jama.2020.3972 Hollander, 2020, Virtually perfect? Telemedicine for Covid-19, N Engl J Med, 10.1056/NEJMp2003539 Rimmer, 2020, Covid-19: medical conferences around the world are cancelled after US cases are linked to Massachusetts meeting, BMJ, 368, m1054, 10.1136/bmj.m1054 European Society of Hypertension. Statement of the European Society of Hypertension (ESH) on hypertension. Renin Angiotensin System blockers and COVID-10. Available at: https://www.eshonline.org/spotlights/esh-statement-on-covid-19/. Accessed on March 12, 2020. Tam, 2020, Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China, Circ Cardiovasc Qual Outcomes, 10.1161/CIRCOUTCOMES.120.006631 Fang Lu, 2018, Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States, J Am Heart Assoc, 7 Williams, 2018, J Hypertens, 36, 1953, 10.1097/HJH.0000000000001940